Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Tables)

6 Months Ended

Jun. 29, 2025

Schedule of Basic and Diluted Earnings Per Share


The following presents the detailed calculation of EPS:
	Three Months Ended				Six Months Ended
(MILLIONS)	June 29, 2025		June 30, 2024		June 29, 2025		June 30, 2024
EPS Numerator


Income from continuing operations attributable to Pfizer Inc. common shareholders	$	2,885	$	24	$	5,852	$	3,144
Discontinued operations––net of tax	25		17		25		12


Net income attributable to Pfizer Inc. common shareholders	$	2,910	$	41	$	5,877	$	3,156




EPS Denominator
Weighted-average number of common shares outstanding––Basic	5,685		5,666		5,680		5,662
Common-share equivalents	21		29		28		35
Weighted-average number of common shares outstanding––Diluted	5,706		5,696		5,708		5,696
Anti-dilutive common stock equivalents(a)	8		23		12		24

(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.